688221 前沿生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-15.056-16.214-21.828-20.377-13.090
总资产报酬率 ROA (%)-9.266-10.191-14.457-14.434-10.301
投入资产回报率 ROIC (%)-9.987-11.013-15.867-15.742-11.050

边际利润分析
销售毛利率 (%)34.84233.92728.99518.605-30.438
营业利润率 (%)-154.271-155.317-286.857-421.616-660.429
息税前利润/营业总收入 (%)-155.578-149.998-281.255-421.061-667.212
净利润/营业总收入 (%)-154.593-155.540-287.935-421.008-654.939

收益指标分析
经营活动净收益/利润总额(%)99.482137.158106.828111.148119.975
价值变动净收益/利润总额(%)4.070-41.799-5.065-5.590-14.330
营业外收支净额/利润总额(%)0.2080.1440.374-0.144-0.838

偿债能力分析
流动比率 (X)2.7053.0942.9015.0723.949
速动比率 (X)2.5802.9902.7464.8713.852
资产负债率 (%)40.05637.01937.26230.67027.734
带息债务/全部投入资本 (%)20.83920.97214.0507.5879.575
股东权益/带息债务 (%)312.409321.530486.4361,009.651813.142
股东权益/负债合计 (%)149.652170.135168.373226.052260.565
利息保障倍数 (X)157.898-27.062-42.1077,917.32554.367

营运能力分析
应收账款周转天数 (天)122.804135.910156.202124.219240.922
存货周转天数 (天)179.522210.543254.308245.900177.669